| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A case of one lung adenocarcinoma patient harboring a novel FAM179A-ALK (F1, A19) rearrangement responding to lorlatinib treatment
|
Yan, Jing
|
|
|
147 |
C |
p. 26-29
|
artikel
|
| 2 |
Acceptability and accuracy of patient-reported outcome measures (PROMs) for surveillance of breathlessness in routine lung cancer care: A mixed-method study
|
Sung, Ji Hyun
|
|
|
147 |
C |
p. 1-11
|
artikel
|
| 3 |
Afatinib in patients with advanced non-small cell lung cancer harboring HER2 mutations, previously treated with chemotherapy: A phase II trial
|
Fan, Yun
|
|
|
147 |
C |
p. 209-213
|
artikel
|
| 4 |
Analysis of pneumonitis and esophageal injury after stereotactic body radiation therapy for ultra-central lung tumors
|
Wang, Chunyu
|
|
|
147 |
C |
p. 45-48
|
artikel
|
| 5 |
Apatinib in combination with pemetrexed-platinum chemotherapy for chemo-naive non-squamous non-small cell lung cancer: a phase II clinical study
|
Yang, Guangjian
|
|
|
147 |
C |
p. 229-236
|
artikel
|
| 6 |
A Phase 2 Study of Tislelizumab in Combination With Platinum-Based Chemotherapy as First-line Treatment for Advanced Lung Cancer in Chinese Patients
|
Wang, Zhijie
|
|
|
147 |
C |
p. 259-268
|
artikel
|
| 7 |
Association between the mutational smoking signature and the immune microenvironment in lung adenocarcinoma
|
Sato, Kei
|
|
|
147 |
C |
p. 12-20
|
artikel
|
| 8 |
Cell-free Chromatin Immunoprecipitation (cfChIP) from blood plasma can determine gene-expression in tumors from non-small-cell lung cancer patients
|
Vad-Nielsen, Johan
|
|
|
147 |
C |
p. 244-251
|
artikel
|
| 9 |
Contents
|
|
|
|
147 |
C |
p. v-vi
|
artikel
|
| 10 |
Cribriform growth pattern in lung adenocarcinoma: More aggressive and poorer prognosis than acinar growth pattern
|
Yang, Fujun
|
|
|
147 |
C |
p. 187-192
|
artikel
|
| 11 |
Crizotinib inhibits activation of MET pathway caused by MET extracellular SEMA domain duplication
|
Lin, Jiatong
|
|
|
147 |
C |
p. 64-70
|
artikel
|
| 12 |
Downregulation of CYLD promotes IFN-γ mediated PD-L1 expression in thymic epithelial tumors
|
Umemura, Shigeki
|
|
|
147 |
C |
p. 221-228
|
artikel
|
| 13 |
Editorial Board
|
|
|
|
147 |
C |
p. iii
|
artikel
|
| 14 |
Effectiveness and prognostic factors of first-line crizotinib treatment in patients with ROS1-rearranged non-small cell lung cancer: A multicenter retrospective study
|
Zheng, Jing
|
|
|
147 |
C |
p. 130-136
|
artikel
|
| 15 |
Efficacy and safety of neoadjuvant immunotherapy in resectable nonsmall cell lung cancer: A meta-analysis
|
Jia, Xiao-hui
|
|
|
147 |
C |
p. 143-153
|
artikel
|
| 16 |
Endobronchial ultrasound- guided transbronchial needle aspiration for mediastinal lymph node staging in patients with typical pulmonary carcinoids
|
Vial, Macarena R.
|
|
|
147 |
C |
p. 198-203
|
artikel
|
| 17 |
Enhanced prognostic stratification of neoadjuvant treated lung squamous cell carcinoma by computationally-guided tumor regression scoring
|
Casanova, Ruben
|
|
|
147 |
C |
p. 49-55
|
artikel
|
| 18 |
Final overall survival and safety update for durvalumab in third- or later-line advanced NSCLC: The phase II ATLANTIC study
|
Garassino, Marina Chiara
|
|
|
147 |
C |
p. 137-142
|
artikel
|
| 19 |
Gene expression profiling by targeted RNA sequencing in pathological stage I lung adenocarcinoma with a solid component
|
Kidokoro, Yoshiteru
|
|
|
147 |
C |
p. 56-63
|
artikel
|
| 20 |
Genetic association of gemcitabine/carboplatin-induced leukopenia and neutropenia in non-small cell lung cancer patients using whole-exome sequencing
|
Svedberg, Anna
|
|
|
147 |
C |
p. 106-114
|
artikel
|
| 21 |
Histopathological subtyping is a prognostic factor in stage IV lung adenocarcinoma
|
Da Cruz, Vanessa
|
|
|
147 |
C |
p. 77-82
|
artikel
|
| 22 |
HOTAIR induces EGFR-TKIs resistance in non-small cell lung cancer through epithelial-mesenchymal transition
|
Wang, Qi
|
|
|
147 |
C |
p. 99-105
|
artikel
|
| 23 |
International real-world study of DLL3 expression in patients with small cell lung cancer
|
Rojo, Federico
|
|
|
147 |
C |
p. 237-243
|
artikel
|
| 24 |
Machine learning-based histological classification that predicts recurrence of peripheral lung squamous cell carcinoma
|
Koike, Yutaro
|
|
|
147 |
C |
p. 252-258
|
artikel
|
| 25 |
Malignant pleural mesothelioma: Treatment patterns and outcomes from the Spanish Lung Cancer Group
|
Remon, J.
|
|
|
147 |
C |
p. 83-90
|
artikel
|
| 26 |
Mechanisms of osimertinib resistance and emerging treatment options
|
Schmid, Sabine
|
|
|
147 |
C |
p. 123-129
|
artikel
|
| 27 |
MiR-320a is associated with cisplatin resistance in lung adenocarcinoma and its clinical value in non-small cell lung cancer: A comprehensive analysis based on microarray data
|
Lu, Min
|
|
|
147 |
C |
p. 193-197
|
artikel
|
| 28 |
Pembrolizumab-induced severe oral mucositis in a patient with squamous cell carcinoma of the lung: A case study
|
Yoon, Soo-Young
|
|
|
147 |
C |
p. 21-25
|
artikel
|
| 29 |
Prognostic significance of low pectoralis muscle mass on preoperative chest computed tomography in localized non-small cell lung cancer after curative-intent surgery
|
Sun, Changbo
|
|
|
147 |
C |
p. 71-76
|
artikel
|
| 30 |
Prognostic value of tumor-infiltrating lymphocytes (TILs) and their association with PD-L1 expression and DNA repair protein RAD51 in patients with resected non-small cell lung carcinoma
|
Gachechiladze, Mariam
|
|
|
147 |
C |
p. 30-38
|
artikel
|
| 31 |
Pulmonary adenocarcinoma with psammoma bodies is associated with a specific endobronchial ultrasound pattern and a high prevalence of actionable driver mutations
|
Trisolini, Rocco
|
|
|
147 |
C |
p. 204-208
|
artikel
|
| 32 |
Radiological-pathological correlation of subsolid pulmonary nodules: A single centre retrospective evaluation of the 2011 IASLC adenocarcinoma classification system
|
Roberts, James M.
|
|
|
147 |
C |
p. 39-44
|
artikel
|
| 33 |
Retrospective study of the incidence and outcomes from lung cancer in solid organ transplant recipients
|
Young, Kelvin
|
|
|
147 |
C |
p. 214-220
|
artikel
|
| 34 |
Risk-Based lung cancer screening: A systematic review
|
Toumazis, Iakovos
|
|
|
147 |
C |
p. 154-186
|
artikel
|
| 35 |
Spatial heterogeneity of PD-L1 expression and the risk for misclassification of PD-L1 immunohistochemistry in non-small cell lung cancer
|
Ben Dori, Shani
|
|
|
147 |
C |
p. 91-98
|
artikel
|
| 36 |
The rates of second lung cancers and the survival of surgically-resected second primary lung cancers in patients undergoing resection of an initial primary lung cancer
|
Varlotto, J.M.
|
|
|
147 |
C |
p. 115-122
|
artikel
|
Tijdschrift beschrijving